Shanghai Henlius Biotech (HKSE:02696) EV-to-FCF : 76.85 (As of Jul. 08, 2025)

Shanghai Henlius Biotech EV-to-FCF Chart

Shanghai Henlius Biotech Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-FCF	Get a 7-Day Free Trial										-24.05	-	274.48	-	36.92

Competitive Comparison of Shanghai Henlius Biotech's EV-to-FCF

For the Biotechnology subindustry, Shanghai Henlius Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Henlius Biotech's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Henlius Biotech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Henlius Biotech's EV-to-FCF falls into.

Shanghai Henlius Biotech EV-to-FCF Calculation

Shanghai Henlius Biotech's EV-to-FCF for today is calculated as:

Shanghai Henlius Biotech's current Enterprise Value is HK$33,069 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Henlius Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was HK$430 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Henlius Biotech  (HKSE:02696) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Henlius Biotech's PE Ratio (TTM) for today is calculated as:

Shanghai Henlius Biotech's share price for today is HK$54.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Henlius Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$1.618.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Shanghai Henlius Biotech EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Henlius Biotech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Henlius Biotech Business Description